Unknown

Dataset Information

0

Acyl-CoA synthetase 6 enriches the neuroprotective omega-3 fatty acid DHA in the brain.

ABSTRACT: Docosahexaenoic acid (DHA) is an omega-3 fatty acid that is highly abundant in the brain and confers protection against numerous neurological diseases, yet the fundamental mechanisms regulating the enrichment of DHA in the brain remain unknown. Here, we have discovered that a member of the long-chain acyl-CoA synthetase family, Acsl6, is required for the enrichment of DHA in the brain by generating an Acsl6-deficient mouse (Acsl6-/-). Acsl6 is highly enriched in the brain and lipid profiling of Acsl6-/- tissues reveals consistent reductions in DHA-containing lipids in tissues highly abundant with Acsl6. Acsl6-/- mice demonstrate motor impairments, altered glutamate metabolism, and increased astrogliosis and microglia activation. In response to a neuroinflammatory lipopolysaccharide injection, Acsl6-/- brains show similar increases in molecular and pathological indices of astrogliosis compared with controls. These data demonstrate that Acsl6 is a key mediator of neuroprotective DHA enrichment in the brain.

SUBMITTER: Fernandez RF 

PROVIDER: S-EPMC6298081 | biostudies-other | 2018 Dec

REPOSITORIES: biostudies-other

Json Xml
altmetric image

Publications

Acyl-CoA synthetase 6 enriches the neuroprotective omega-3 fatty acid DHA in the brain.

Fernandez Regina F RF   Kim Sora Q SQ   Zhao Yingwei Y   Foguth Rachel M RM   Weera Marcus M MM   Counihan Jessica L JL   Nomura Daniel K DK   Chester Julia A JA   Cannon Jason R JR   Ellis Jessica M JM  

Proceedings of the National Academy of Sciences of the United States of America 20181106 49

Docosahexaenoic acid (DHA) is an omega-3 fatty acid that is highly abundant in the brain and confers protection against numerous neurological diseases, yet the fundamental mechanisms regulating the enrichment of DHA in the brain remain unknown. Here, we have discovered that a member of the long-chain acyl-CoA synthetase family, Acsl6, is required for the enrichment of DHA in the brain by generating an Acsl6-deficient mouse (Acsl6<sup>-/-</sup>). Acsl6 is highly enriched in the brain and lipid pr  ...[more]

Similar Datasets

Unknown Elucidating the Pseudomonas aeruginosa fatty acid degradation pathway: identification of additional fatty acyl-CoA synthetase homologues.
| S-EPMC3667196 | biostudies-literature
Unknown FATP2 is a hepatic fatty acid transporter and peroxisomal very long-chain acyl-CoA synthetase.
| S-EPMC2944282 | biostudies-literature
Unknown Activity of the acyl-CoA synthetase ACSL6 isoforms: role of the fatty acid Gate-domains.
| S-EPMC2868784 | biostudies-literature
Unknown Targeting of Acyl-CoA synthetase 5 decreases jejunal fatty acid activation with no effect on dietary long-chain fatty acid absorption.
| S-EPMC3699395 | biostudies-literature
Unknown Hepatic long-chain acyl-CoA synthetase 5 mediates fatty acid channeling between anabolic and catabolic pathways.
| S-EPMC2952567 | biostudies-literature
Unknown Acyl-CoA synthetase 6 is required for brain docosahexaenoic acid retention and neuroprotection during aging.
| S-EPMC8262339 | biostudies-literature
Unknown Long-Chain Acyl-CoA Synthetase 4-Mediated Fatty Acid Metabolism Sustains Androgen Receptor Pathway-Independent Prostate Cancer.
| S-EPMC7785683 | biostudies-literature
Unknown Fatty Acid Oxidation Mediated by Acyl-CoA Synthetase Long Chain 3 Is Required for Mutant KRAS Lung Tumorigenesis.
| S-EPMC4981512 | biostudies-literature
Unknown TANK-Binding Kinase 1 Regulates the Localization of Acyl-CoA Synthetase ACSL1 to Control Hepatic Fatty Acid Oxidation.
| S-EPMC7710607 | biostudies-literature
Unknown Long-chain acyl-CoA synthetases and fatty acid channeling.
| S-EPMC2846691 | biostudies-literature